{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:31:00Z","timestamp":1773837060995,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273825"],"award-info":[{"award-number":["82273825"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bioorg.2025.109276","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:30:22Z","timestamp":1763659822000},"page":"109276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synthesis of self-immolative NO donor-aurovertin B conjugate as potent anti-triple negative breast cancer agents"],"prefix":"10.1016","volume":"167","author":[{"given":"Yi-Li","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Zhu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zha-Jun","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luo","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lie-Feng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109276_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108558","article-title":"Therapeutic approach for triple-negative breast cancer through poly (ADP-ribose) polymerase-1 inhibitors: Current update","volume":"163","author":"Das","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109276_bb0010","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/cncr.23243","article-title":"The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer - the california cancer registry, 1999-2004","volume":"112","author":"Brown","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.bioorg.2025.109276_bb0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/cncr.28914","article-title":"Subtyping of triple-negative breast cancer: Implications for therapy","volume":"121","author":"Abramson","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.bioorg.2025.109276_bb0020","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.561","article-title":"Incidence of PI3K pathway alteration and response to neoadjuvant therapy (NAT) in triple negative breast cancer (TNBC) subtypes","volume":"38","author":"Basho","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2025.109276_bb0025","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1007\/s00253-018-9123-1","article-title":"Synthesis and production of the antitumor polyketide aurovertins and structurally related compounds","volume":"102","author":"Li","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bioorg.2025.109276_bb0030","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/hlca.201600026","article-title":"Aurovertin-type polyketides from calcarisporium arbuscula with potent cytotoxic activities against triple-negative breast cancer","volume":"99","author":"Zhao","year":"2016","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.bioorg.2025.109276_bb0035","first-page":"88","article-title":"Biological and chemical properties of aurovertin: A metabolic product of calcarisporium arbuscula","volume":"27","author":"Baldwin","year":"1964","journal-title":"Lloydia"},{"key":"10.1016\/j.bioorg.2025.109276_bb0040","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/ja.2005.53","article-title":"Aurovertin e, a new polyene pyrone from the basidiomycete albatrellus confluens","volume":"58","author":"Wang","year":"2005","journal-title":"J. Antibiot."},{"key":"10.1016\/j.bioorg.2025.109276_bb0045","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1021\/np070494e","article-title":"Aurovertins F-H from the entomopathogenic fungus Metarhizium anisopliae","volume":"71","author":"Azumi","year":"2008","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2025.109276_bb0050","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1021\/jf903259n","article-title":"Nematodetoxic aurovertin-type metabolites from a root-knot nematode parasitic fungus Pochonia chlamydosporia","volume":"58","author":"Niu","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bioorg.2025.109276_bb0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s13659-012-0088-y","article-title":"Ten new aurovertins from cultures of the basidiomycete Albatrellus confluens","volume":"3","author":"Guo","year":"2013","journal-title":"Nat. Prod. Bioprosp."},{"key":"10.1016\/j.bioorg.2025.109276_bb0060","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1016\/S0021-9258(19)57221-0","article-title":"Interaction between aurovertin and adenine nucleotide binding sites on mitochondrial F1-atpase and the isolated beta subunit","volume":"261","author":"Lunardi","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.109276_bb0065","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.1073\/pnas.93.14.6913","article-title":"The structure of bovine F1-atpase complexed with the antibiotic inhibitor aurovertin B","volume":"93","author":"Van Raaij","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2025.109276_bb0070","first-page":"261","article-title":"Aurovertin B exerts potent antitumor activity against triple-negative breast cancer in vivo and in vitro via regulating ATP synthase activity and DUSP1 expression","volume":"75","author":"Wu","year":"2020","journal-title":"Pharmazie"},{"key":"10.1016\/j.bioorg.2025.109276_bb0075","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1021\/pr700742h","article-title":"Targeting therapy for breast carcinoma by ATP synthase inhibitor aurovertin B","volume":"7","author":"Huang","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bioorg.2025.109276_bb0080","first-page":"60","article-title":"Study on preparation of twin drug of ibuprofen and paracetamol and its recrystallization","volume":"45","author":"Jiang","year":"2017","journal-title":"Guangzhou Chemical Industry"},{"key":"10.1016\/j.bioorg.2025.109276_bb0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.taap.2017.03.027","article-title":"Developmental neurotoxicity of different pesticides in PC-12 cells in vitro","volume":"325","author":"Christen","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109276_bb0090","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/ph17020209","article-title":"Antibacterial potential of symmetrical twin-drug 3,6-diaminoxanthones","volume":"17","author":"Resende","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2025.109276_bb0095","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fpls.2013.00425","article-title":"Nitric oxide in guard cells as an important secondary messenger during stomatal closure","volume":"4","author":"Gayatri","year":"2013","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.bioorg.2025.109276_bb0100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.cr.7290133","article-title":"The role of nitric oxide in cancer","volume":"12","author":"Xu","year":"2003","journal-title":"Cell Res."},{"key":"10.1016\/j.bioorg.2025.109276_bb0105","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jneumeth.2015.02.024","article-title":"Characterisation and comparison of temporal release profiles of nitric oxide generating donors","volume":"245","author":"Bradley","year":"2015","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bioorg.2025.109276_bb0110","doi-asserted-by":"crossref","first-page":"13089","DOI":"10.1021\/acs.jmedchem.4c01070","article-title":"Discovery of NO donor-aurovertin hybrids as dual ferroptosis and apoptosis inducers for treating triple negative breast cancer","volume":"67","author":"Ma","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109276_bb0115","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1039\/b922341j","article-title":"Self-immolative dendrimers: A distinctive approach to molecular amplification","volume":"6","author":"Avital-Shmilovici","year":"2010","journal-title":"Soft Matter"},{"key":"10.1016\/j.bioorg.2025.109276_bb0120","doi-asserted-by":"crossref","first-page":"7492","DOI":"10.1002\/anie.201500088","article-title":"Self-immolative spacers: Kinetic aspects, structure-property relationships, and applications","volume":"54","author":"Alouane","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2025.109276_bb0125","doi-asserted-by":"crossref","first-page":"9540","DOI":"10.1021\/ja102595j","article-title":"UV and near-IR triggered release from polymeric nanoparticles","volume":"132","author":"Fomina","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.109276_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122281","article-title":"Recent progress of self-immobilizing and self-precipitating molecular fluorescent probes for higher-spatial-resolution imaging","volume":"301","author":"Yan","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioorg.2025.109276_bb0135","doi-asserted-by":"crossref","first-page":"13099","DOI":"10.1021\/jacs.3c01666","article-title":"Self-immolative photosensitizers for self-reported cancer phototheranostics","volume":"145","author":"Wang","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.109276_bb0140","article-title":"Self-immolative activatable nanoassembly toward immuno-photodynamic therapy in TME","author":"Li","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bioorg.2025.109276_bb0145","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1021\/acsnano.1c10231","article-title":"A metabolic multistage glutathione depletion used for tumor-specific chemodynamic therapy","volume":"16","author":"Huang","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioorg.2025.109276_bb0150","doi-asserted-by":"crossref","first-page":"8690","DOI":"10.1021\/acs.nanolett.9b03340","article-title":"Gradient redox-responsive and two-stage rocket-mimetic drug delivery system for improved tumor accumulation and safe chemotherapy","volume":"19","author":"Jia","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioorg.2025.109276_bb0155","first-page":"2845","article-title":"Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs","volume":"46","author":"Russo","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2025.109276_bb0160","doi-asserted-by":"crossref","first-page":"20407","DOI":"10.1021\/jacs.9b10769","article-title":"Diacylfuroxans are masked nitrile oxides that inhibit GPX4 covalently","volume":"141","author":"Eaton","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.109276_bb0165","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1021\/jm1014814","article-title":"Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: Synthesis and evaluation of antihepatocellular carcinoma activity","volume":"54","author":"Ling","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109276_bb0170","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1021\/jm200577a","article-title":"Discovery of a tetrahydroisoquinoline-based hydroxamic acid derivative (ZYJ-34c) as histone deacetylase inhibitor with potent oral antitumor activities","volume":"54","author":"Zhang","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109276_bb0175","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2025.109276_bb0180","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","article-title":"Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis","volume":"172","author":"Ingold","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2025.109276_bb0185","doi-asserted-by":"crossref","first-page":"9041","DOI":"10.1021\/bi700840d","article-title":"Structural basis for catalytic activity and enzyme polymerization of phospholipid hydroperoxide glutathione peroxidase-4 (GPx4)","volume":"46","author":"Scheerer","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2025.109276_bb0190","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jchromb.2005.03.045","article-title":"A thin layer chromatographic method for determining the enzymatic activity of peroxidases catalyzing the two-electron reduction of lipid hydroperoxides","volume":"827","author":"Kriska","year":"2005","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.bioorg.2025.109276_bb0195","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2025.109276_bb0200","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/anie.202012237","article-title":"Activatable mitochondria-targeting organoarsenic prodrugs for bioenergetic cancer therapy","volume":"60","author":"Luo","year":"2021","journal-title":"Angew. Chem. Int. Ed."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825011563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825011563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:12:45Z","timestamp":1773825165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825011563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":40,"alternative-id":["S0045206825011563"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109276","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of self-immolative NO donor-aurovertin B conjugate as potent anti-triple negative breast cancer agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109276","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109276"}}